Criterica Intelligence — production models trained on real court records, not synthetic data
EBSA · Civil Investigations Closed · FY2023

EBSA Civil Investigations Closed, Fiscal Year 2023

Civil investigations into plan fiduciaries, service providers, and administrators that EBSA closed in the fiscal year, with or without an enforcement outcome.

Sourced Figures

Year-Over-Year

Investigations closed fell again to 731, the lowest in the window to that point.

What Changed in FY2023

Mental health parity enforcement intensified — EBSA reported devoting close to 25% of its enforcement program to non-quantitative treatment limitation review, investigating 102 health plans (51 specifically for parity compliance, finding 31 violations across 17 investigations), following its July 2023 Comparative Analysis Report to Congress.

Criterica Intelligence Read

EBSA's civil investigation count is a volume measure, not a violation-rate measure, and the distinction matters for anyone using it to gauge plan-sponsor exposure: a large share of closed civil investigations end with no fiduciary breach found, a corrected deficiency, or a voluntary compliance outcome, not a litigated enforcement action. Reading the closed-investigations total as a proxy for how many plans are "in trouble" in a given year overstates the risk; the more useful reading is as a proxy for where EBSA is allocating its limited investigative capacity — which plan types, which fiduciary practices, which service-provider relationships are drawing the most scrutiny.

Duration for civil investigations varies enormously by scope: a targeted investigation following a participant complaint about a specific transaction can close within months, while a broad investigation into a service provider's fee arrangements across multiple plan clients, or a cybersecurity-practices review following EBSA's 2021 guidance, can run for years and touch dozens of plans before closing. A plan sponsor or fiduciary under investigation has limited ability to predict which category their matter falls into from the outset, which is precisely the uncertainty a calibrated duration model is built to characterize rather than assume away with a single average.

For insurers writing fiduciary liability coverage, and for plan sponsors and their counsel budgeting for a pending investigation, the closed-investigations trend by itself says little about individual exposure; what matters is the enforcement-outcome mix behind the closures in a given year — how many closed with a monetary recovery, how many with a referral for further action, how many with no finding at all. A year with a high closure count but a low enforcement-outcome rate signals expanded investigative reach without a corresponding rise in individual plan risk, while the reverse signals the opposite.

Resolution paths for civil investigations lean heavily toward voluntary correction and negotiated recovery agreements rather than litigation, consistent with EBSA's stated preference for correcting fiduciary breaches and restoring plan losses over adversarial proceedings wherever the facts allow. Criterica Intelligence frames the closed-investigations count as an investigative-capacity signal to be read alongside the enforcement-outcome mix, not a standalone exposure measure, for the plan sponsors, insurers, and funders that need to separate volume from violation risk.

See How EBSA Patterns Inform Duration Intelligence
Frequently Asked Questions
How many civil investigations closed did the EBSA report for FY2023?

Civil investigations closed: 731, per DOL EBSA Fact Sheet: Fiscal Year 2023 EBSA Enforcement (as of 2023-11-01).

How does FY2023 compare with the prior fiscal year?

Investigations closed fell again to 731, the lowest in the window to that point.

What is a notable EBSA action from FY2023?

No individually named, sourced action for FY2023 has been confirmed for this category yet.

What changed in EBSA enforcement priorities in FY2023?

Mental health parity enforcement intensified — EBSA reported devoting close to 25% of its enforcement program to non-quantitative treatment limitation review, investigating 102 health plans (51 specifically for parity compliance, finding 31 violations across 17 investigations), following its July 2023 Comparative Analysis Report to Congress.

Figures on this page are drawn from official agency publications, cited individually below, and reflect the agency’s own reporting as of the date shown for each figure. They are not Criterica Intelligence model outputs, are not predictions, and are not a measure of any party’s legal exposure or liability. Agencies periodically revise prior-year figures; where a revision is known, both figures are shown with their sources. This page does not constitute legal, investment, or compliance advice.

Talk to Us